{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:15:35Z","timestamp":1771488935821,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903875"],"award-info":[{"award-number":["81903875"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejphar.2020.173634","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T03:14:50Z","timestamp":1601954090000},"page":"173634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Tissue distributions of antiviral drugs affect their capabilities of reducing viral loads in COVID-19 treatment"],"prefix":"10.1016","volume":"889","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173634_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2020.173634_bib2","series-title":"Experimental Treatment with Favipiravir for COVID-19: an Open-Label Control Study. Engineering","author":"Cai","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173634_bib3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2020.173634_bib4","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2020.173634_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.05.085","article-title":"Lack of antiviral activity of darunavir against SARS-CoV-2","author":"De Meyer","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.ejphar.2020.173634_bib6","first-page":"489","article-title":"Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans","volume":"25","author":"Denissen","year":"1997","journal-title":"Drug Metabol. Dispos.: Biol. Fate Chem."},{"key":"10.1016\/j.ejphar.2020.173634_bib7","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ejphar.2020.173634_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2015.07.003","article-title":"Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever","volume":"121","author":"Gowen","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejphar.2020.173634_bib9","first-page":"259","article-title":"COVID-19: faecal-oral transmission? Nature reviews","volume":"17","author":"Hindson","year":"2020","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2020.173634_bib10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically Proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173634_bib11","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173634_bib12","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1023\/B:PHAM.0000041457.64638.8d","article-title":"Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans","volume":"21","author":"Kumar","year":"2004","journal-title":"Pharmaceut. Res."},{"key":"10.1016\/j.ejphar.2020.173634_bib13","series-title":"Clinical and Virological Data of the First Cases of COVID-19 in Europe: a Case Series. The Lancet","author":"Lescure","year":"2020"},{"key":"10.1016\/j.ejphar.2020.173634_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41597-019-0351-8","article-title":"Single-cell RNA sequencing of human kidney","volume":"7","author":"Liao","year":"2020","journal-title":"Scientific data"},{"key":"10.1016\/j.ejphar.2020.173634_bib15","first-page":"829","article-title":"Distribution and excretion of arbidol hydrochloride in rats","volume":"22","author":"Liu","year":"2013","journal-title":"Chin. J. New Drugs"},{"key":"10.1016\/j.ejphar.2020.173634_bib16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.ejphar.2020.173634_bib17","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1211\/0022357022340","article-title":"Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo","volume":"55","author":"Ono","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173634_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01387-16","article-title":"Clinical isolates of human coronavirus 229E bypass the endosome for cell entry","volume":"91","author":"Shirato","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2020.173634_bib19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2017.11.012","article-title":"Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry","volume":"517","author":"Shirato","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.ejphar.2020.173634_bib20","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejphar.2020.173634_bib21","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2020.173634_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1208\/s12248-020-00459-8","article-title":"Remdesivir for treatment of COVID-19: combination of Pulmonary and IV administration may offer aditional benefit","volume":"22","author":"Sun","year":"2020","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2020.173634_bib23","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2020.173634_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ejphar.2020.173634_bib25","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15102","article-title":"Lung tissue distribution of drugs as a key factor for COVID-19 treatment","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2020.173634_bib26","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2020.173634_bib27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/chir.530070807","article-title":"Stereoselective disposition of hydroxychloroquine and its metabolite in rats","volume":"7","author":"Wei","year":"1995","journal-title":"Chirality"},{"key":"10.1016\/j.ejphar.2020.173634_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"Wolfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173634_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature22313","article-title":"Non-equivalence of Wnt and R-spondin ligands during Lgr5(+) intestinal stem-cell self-renewal","volume":"545","author":"Yan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2020.173634_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","author":"Ziegler","year":"2020","journal-title":"Cell"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920307263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:41:20Z","timestamp":1757976080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920307263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":30,"alternative-id":["S0014299920307263"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173634","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue distributions of antiviral drugs affect their capabilities of reducing viral loads in COVID-19 treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173634","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173634"}}